IP Library › Granted Patent US 9,700,616
Granted Patent B2
US 9,700,616 · App. 15/076,776 · Granted Jul 11, 2017

Arranging interaction and back pressure chambers for microfluidization

Inventors: Harald Rueckl (Alsfeld, DE); Hanno Scheffczik (Marburg, DE)
Assignee: NOVARTIS AG
A61K39/39A61K9/0019A61K9/107A61K9/1075A61K31/164A61K39/145A61K47/14A61K47/26A61K47/44B01F3/0807B01F7/00766B01F13/0064B01F13/1016A61K2039/55555A61K2039/55566B01F5/0644B01F13/0059B01F13/0071B01F13/103B01F13/1013B01F13/1025B01F13/1027B01F2003/0834B01F2003/0842B01F2215/045B01F2215/0481G01N33/48728
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,700,616
App. No.
15/076,776
Granted
Jul 11, 2017
Kind
B2
Abstract

An improved method for the manufacture of an oil-in-water emulsion comprises using a microfluidisation device whose interaction chamber comprises a plurality of Z-type channels upstream of a back pressure chamber.

Claims (9)

1. A microfluidization apparatus for microfluidizing a first oil-in-water emulsion to produce a second oil-in-water emulsion, said apparatus comprising an interaction chamber, at least one intensifier pump, and a back pressure chamber,

wherein:

the interaction chamber comprises a plurality of Z-type geometry channels,

the back pressure chamber comprises a plurality of fixed geometry channels and is located downstream of the interaction chamber, wherein said back pressure chamber is configured to reduce the average oil droplet size and/or the number of oil droplets with a size >1.2 μm in an emulsion that enters the back pressure chamber from the interaction chamber and exits from the back pressure chamber thereby producing the second emulsion; and

the oil-in-water emulsions comprise squalene and water.

2. The microfluidization apparatus according to claim 1 , wherein the second emulsion has an average oil droplet size of 500 nm or less.

3. The microfluidization apparatus according to claim 2 , wherein the oil-in-water emulsion further comprises polysorbate 80, and sorbitan trioleate.

4. The microfluidization apparatus of claim 1 , wherein the interaction chamber provides a shear rate in excess of 1×10 6 s −1 .

5. The microfluidization apparatus according to claim 1 , wherein the pressure of the emulsion components at the entrance to the interaction chamber is substantially constant for at least 85% of the time during which the emulsion is feed into the microfluidization apparatus.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2024
From: NOVARTIS AG
To: SEQIRUS UK LIMITED
Reel/Frame 069642/0293 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2016
From: RUECKL, HARALD; SCHEFFCZIK, HANNO
To: NOVARTIS VACCINES AND DIAGNOSTICS GMBH
Reel/Frame 038382/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2016
From: NOVARTIS VACCINES AND DIAGNOSTICS GMBH
To: NOVARTIS AG
Reel/Frame 038383/0178 →
Continuity (4)
Continuation 14657165 · Mar 13, 2015
Continuation 13513560
Provisional Application 61283548 · Dec 3, 2009
Related Publication 20160199486A1 · Jul 14, 2016